You are here: Industry Insights > COVID-19 Vaccine

News List

EC signs first Covid-19 vaccine contract with AstraZeneca pharmaceutical-technology
August 28, 2020
The European Commission (EC) has signed its first contract with AstraZeneca for the supply of a Covid-19 vaccine candidate to the European Union (EU) Member States.
Akers, Premas note positive proof-of-concept data of Covid-19 vaccine contractpharma
August 28, 2020
Akers Biosciences and Premas Biotech have reported positive proof-of-concept data from animal studies of their PRAK-03202 vaccine candidate against Covid-19.
Premas Biotech’s COVID-19 vaccine candidate sees neutralising immune response in animal studies expresspharma
August 28, 2020
The company announced that it is in talks with regulatory authorities for human trials of its triple antigen vaccine.
Sinovac signs agreement with Bio Farma Indonesia for Covid-19 vaccine cooperation pharmaceutical-business-review
August 27, 2020
Sinovac Biotech, a leading provider of biopharmaceutical products in China, announced it has signed two agreements in Hainan, China with PT Bio Farma, a leading biopharmaceutical company in Indonesia, for the supply ...
Scancell receives funding for COVID-19 vaccine development pharmatimes
August 27, 2020
Scancell Holdings has secured funding of around £2 million from Innovate UK to initiate a Phase I clinical trial of an experimental SARS-CoV-2 vaccine.
COVID-19 vaccines need novel approaches to ensure best balance of safety and efficacy: GlobalData expresspharma
August 27, 2020
AstraZeneca’s AZD-1222 and Moderna’s mRNA-1273 are currently the most promising vaccine candidates, it states.
Moderna informs COVID-19 vaccine induced immune response in older adults in small study expresspharma
August 27, 2020
The latest data from an early Phase I study includes an analysis from 20 additional people detailing how the vaccine performed in older adults.
First patients enrolled in Phase II trial of Novavax COVID-19 vaccine europeanpharmaceuticalreview
August 26, 2020
The Phase II clinical trial to study NVX-CoV2373, the Novavax COVID-19 vaccine candidate, has enrolled its first patient.
Translate Bio, Sanofi Covid-19 vaccine elicits immune response in animals pharmaceutical-technology
August 26, 2020
Translate Bio has reported that its Covid-19 vaccine candidate, being developed in collaboration with Sanofi, elicited immune response in early-stage animal studies.
AstraZeneca’s COVID-19 vaccine data may fall short of desirable protection results: GlobalData expresspharma
August 26, 2020
The ongoing early study only requires 30 COVID-19 cases to detect vaccine efficacy, which is much too small to be sure of protection and would only be suitable to support other larger trials, it states.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page